Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Eureka Genomics Lands a NIFA Award for $100,000

Published: Thursday, June 28, 2012
Last Updated: Thursday, June 28, 2012
Bookmark and Share
Development of bovine parentage genotyping by highly multiplex next generation sequencing.

The National Institute of Food and Agriculture (NIFA), USDA issued a $100,000 award for the development of Bovine Parentage Genotyping by Highly Multiplex Next Generation Sequencing.

This project is related to a Cooperative Research and Development Agreement (CRADA) between Eureka Genomics and the Agricultural Research Service, USDA to develop a low cost, low-density marker assay (LDMA) focused on the bovine industry.

The core technology for low cost high-throughput genotyping will have applications across animal, plant and clinical markets.

"The collaboration has resulted in a very cost-effective, high-throughput approach to single nucleotide polymorphism (SNP) genotyping, which is currently available for bovine parentage testing as well as for custom applications. Continuing development efforts are focused on increasing the number of SNPs that can be included in an assay, on further reducing the costs of adding SNP to assays, and on expanding the approach to include additional types of polymorphisms," said Mark Thallman, Ph.D. Research Geneticist and co-inventor of the technology, at the U.S. Meat Animal Research Center.

"The success of and knowledge created during the collaboration between Eureka Genomics and the USDA on LDMA for high-throughput genotyping is being leveraged into an ongoing collaboration between Eureka Genomics and the USDA that has expanded to include many diverse areas including 16S characterization and improved sample handling for next generation sequencing. Eureka Genomics is very pleased to continue to work with the U.S. Meat Animal Research Center to improve the applications of high throughput sequence data in the agricultural setting," said Heather Koshinsky, PhD., CSO, Eureka Genomics.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos